巨一科技(688162.SH):擬使用不超6.11億元募集資金向巨一動力增資以實施募投項目
格隆匯2月24日丨巨一科技(688162.SH)公佈,公司於2022年2月24日召開第一屆董事會第十四次會議、第一屆監事會第十次會議,審議通過了《關於使用部分募集資金向全資子公司增資以實施募投項目的議案》,同意公司使用募集資金不超過6.11億元向全資子公司合肥巨一動力系統有限公司(簡稱“巨一動力”)增資用於實施公司首次公開發行股票的募投項目中“新能源汽車新一代電驅動系統產業化項目”,其中1億元計入註冊資本,其餘5.11億元計入資本公積。本次增資完成後,巨一動力的註冊資本由5000.00萬元增加至1.5億元,巨一動力仍為公司的全資子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.